94 related articles for article (PubMed ID: 25400297)
1. Rationally Designed Macrocyclic Peptides as Synergistic Agonists of LPS-Induced Inflammatory Response.
Gao M; London N; Cheng K; Tamura R; Jin J; Schueler-Furman O; Yin H
Tetrahedron; 2014 Oct; 70(42):7664-7668. PubMed ID: 25400297
[TBL] [Abstract][Full Text] [Related]
2. CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells.
Frleta D; Noelle RJ; Wade WF
J Leukoc Biol; 2003 Dec; 74(6):1064-73. PubMed ID: 12960264
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways.
Dejkhamron P; Thimmarayappa J; Kotlyarevska K; Sun J; Lu C; Bonkowski EL; Denson LA; Menon RK
Mol Cell Endocrinol; 2007 Aug; 274(1-2):35-42. PubMed ID: 17601656
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B
Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
[TBL] [Abstract][Full Text] [Related]
5. The Fab Fragment of a Humanized Anti-Toll Like Receptor 4 (TLR4) Monoclonal Antibody Reduces the Lipopolysaccharide Response via TLR4 in Mouse Macrophage.
Cai B; Wang M; Zhu X; Xu J; Zheng W; Zhang Y; Zheng F; Feng Z; Zhu J
Int J Mol Sci; 2015 Oct; 16(10):25502-15. PubMed ID: 26512658
[TBL] [Abstract][Full Text] [Related]
6. TLR4/MD2 specific peptides stalled in vivo LPS-induced immune exacerbation.
Park S; Shin HJ; Shah M; Cho HY; Anwar MA; Achek A; Kwon HK; Lee B; Yoo TH; Choi S
Biomaterials; 2017 May; 126():49-60. PubMed ID: 28254693
[TBL] [Abstract][Full Text] [Related]
7. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
Kawamoto T; Ii M; Kitazaki T; Iizawa Y; Kimura H
Eur J Pharmacol; 2008 Apr; 584(1):40-8. PubMed ID: 18299127
[TBL] [Abstract][Full Text] [Related]
8. HSP60-Derived Peptide as an LPS/TLR4 Modulator: An
Vila-Casahonda RG; Lozano-Aponte J; Guerrero-Beltrán CE
Front Cardiovasc Med; 2022; 9():731376. PubMed ID: 35433873
[TBL] [Abstract][Full Text] [Related]
9. Discovery of caffeic acid phenethyl ester derivatives as novel myeloid differentiation protein 2 inhibitors for treatment of acute lung injury.
Chen L; Jin Y; Chen H; Sun C; Fu W; Zheng L; Lu M; Chen P; Chen G; Zhang Y; Liu Z; Wang Y; Song Z; Liang G
Eur J Med Chem; 2018 Jan; 143():361-375. PubMed ID: 29202400
[TBL] [Abstract][Full Text] [Related]
10. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
Pinhal-Enfield G; Ramanathan M; Hasko G; Vogel SN; Salzman AL; Boons GJ; Leibovich SJ
Am J Pathol; 2003 Aug; 163(2):711-21. PubMed ID: 12875990
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists.
Peri F; Piazza M
Biotechnol Adv; 2012; 30(1):251-60. PubMed ID: 21664961
[TBL] [Abstract][Full Text] [Related]
12. Regulation of innate immune responses by Toll-like receptors.
Takeda K; Akira S
Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effects of genistein via suppression of the toll-like receptor 4-mediated signaling pathway in lipopolysaccharide-stimulated BV2 microglia.
Jeong JW; Lee HH; Han MH; Kim GY; Kim WJ; Choi YH
Chem Biol Interact; 2014 Apr; 212():30-9. PubMed ID: 24491678
[TBL] [Abstract][Full Text] [Related]
14. PPARγ ameliorated LPS induced inflammation of HEK cell line expressing both human Toll-like receptor 4 (TLR4) and MD2.
Darehgazani R; Peymani M; Hashemi MS; Omrani MD; Movafagh A; Ghaedi K; Nasr-Esfahani MH
Cytotechnology; 2016 Aug; 68(4):1337-48. PubMed ID: 26224481
[TBL] [Abstract][Full Text] [Related]
15. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells.
Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X
Vet Res; 2008; 39(2):11. PubMed ID: 18096120
[TBL] [Abstract][Full Text] [Related]
16. Pivotal advance: vasoactive intestinal peptide inhibits up-regulation of human monocyte TLR2 and TLR4 by LPS and differentiation of monocytes to macrophages.
Foster N; Lea SR; Preshaw PM; Taylor JJ
J Leukoc Biol; 2007 Apr; 81(4):893-903. PubMed ID: 16973891
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia attenuates inflammatory mediators production induced by Acanthamoeba via Toll-like receptor 4 signaling in human corneal epithelial cells.
Pan H; Wu X
Biochem Biophys Res Commun; 2012 Apr; 420(3):685-91. PubMed ID: 22450324
[TBL] [Abstract][Full Text] [Related]
18. [Effects of vasoactive intestinal peptide on Toll-like receptor (TLR) 2 mRNA and TLR4 mRNA expression on acute lung injury induced by lipopolysaccharide in rat].
Zuo WQ; Zhang YC; Gong XH; Zhang YM
Zhonghua Er Ke Za Zhi; 2010 Jan; 48(1):19-23. PubMed ID: 20441697
[TBL] [Abstract][Full Text] [Related]
19. Saturated fatty acids trigger TLR4-mediated inflammatory response.
Rocha DM; Caldas AP; Oliveira LL; Bressan J; Hermsdorff HH
Atherosclerosis; 2016 Jan; 244():211-5. PubMed ID: 26687466
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor (TLR) 2 agonists ameliorate indomethacin-induced murine ileitis by suppressing the TLR4 signaling.
Narimatsu K; Higashiyama M; Kurihara C; Takajo T; Maruta K; Yasutake Y; Sato H; Okada Y; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Hokari R
J Gastroenterol Hepatol; 2015 Nov; 30(11):1610-7. PubMed ID: 25867219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
